Semax Spray

Semax Spray delivers research-grade Semax, a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from a fragment of ACTH(4-10), formulated as a liquid spray solution rather than a lyophilized powder. This delivery format supports laboratory protocols examining mucosal membrane absorption and comparative administration-route pharmacokinetics, offering an alternative research model to reconstituted powder preparations. Each unit is manufactured using the same purity-verified peptide stock used across our Semax product line, ensuring consistent reference standards across formulation types.

Semax research centers on its proposed role as a neurotrophic and nootropic modulator within the central nervous system. The dominant research focus is its apparent influence on brain-derived neurotrophic factor (BDNF) expression, a mechanism widely studied in relation to neuronal plasticity, learning-and-memory models, and neuroprotection under simulated ischemic or oxidative-stress conditions. Semax is also examined for its interaction with the dopaminergic and serotonergic systems, and for enkephalinase-inhibition properties that parallel research on related ACTH-derived and tuftsin-derived neuropeptides such as Selank. Researchers frequently position Semax as a comparator compound in studies benchmarking nootropic neuropeptide mechanisms against classical small-molecule nootropics. The spray delivery format additionally supports research into intranasal and mucosal administration models, an area of interest for researchers studying blood-brain barrier bypass routes and comparative CNS peptide bioavailability. All research applications are conducted exclusively in non-human, in-vitro, and preclinical laboratory models.

Every batch of the Semax peptide used in Semax Spray is synthesized using Solid-Phase Peptide Synthesis (SPPS) and purified via preparative HPLC to eliminate truncated sequences and synthesis byproducts. Final identity confirmation is performed via Electrospray Ionization Mass Spectrometry (ESI-MS), verifying exact molecular weight. Each lot ships with a Certificate of Analysis documenting purity exceeding 99%, giving researchers traceable, batch-specific verification before use in any laboratory protocol. The formulated spray solution is manufactured under controlled laboratory conditions using pharmaceutical-grade solvents and sterile-filtered prior to bottling, ensuring batch-to-batch consistency. Each production lot is traceable to its source peptide batch, and a Certificate of Analysis for the underlying Semax peptide is available on request, documenting purity, identity, and mass verification.

This product is strictly for research and laboratory use only. It is not approved by the FDA or any global regulatory body for human consumption, veterinary use, or therapeutic application. The purchaser assumes all responsibility for the proper handling, storage, and application of this compound. It must only be handled by qualified professionals in a controlled laboratory setting. By purchasing this product, you agree to abide by all local and international laws regarding the use of research chemicals. Semax Spray is classified strictly as a Research Use Only (RUO) compound and is not manufactured, labeled, or sold as a drug, dietary supplement, nootropic aid, or medical device under any applicable regulatory framework. No claims made regarding this product are intended to diagnose, treat, cure, or prevent any disease, or to suggest any cognitive, therapeutic, or performance benefit in humans or animals. This product is sold exclusively to qualified researchers and laboratories for controlled, non-clinical research use, and the buyer assumes full responsibility for compliance with all applicable local, state, federal, and international laws governing its purchase, possession, and use.